Good morning everyone,
"Genta's patent estate related to Genasense is extensive, we have detailed plans for securing rapid approval in Europe with positive data this Fall," said Dr. Raymond P. Warrell, Jr., Genta's Chief Executive Officer.
Well at least a timeline (from Genta) is beginning to unfold. Now we need to to read a release on how they are going to continue financing their operations until fall.
I'm not excited about the release but lets see how they follow through (if they follow through).
Good trading,
prsch3259